38.01 -1.25 (-3.18%)

33.16% Fall from 52W High

57,015 XNAS Volume

XNAS 07 May, 2025 9:51 AM (EDT)

Board Meeting
The board meeting for MoonLake Immunotherapeutics - Ordinary Shares - Class A is scheduled for today, for the purpose of MoonLake Immunotherapeutics First Quarter Earnings Results for 2025 See details